PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.25%
Revenue growth under 50% of META's 12.29%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.61%
Gross profit growth under 50% of META's 12.33%. Michael Burry would be concerned about a severe competitive disadvantage.
4.41%
EBIT growth below 50% of META's 10.27%. Michael Burry would suspect deeper competitive or cost structure issues.
4.41%
Operating income growth under 50% of META's 16.44%. Michael Burry would be concerned about deeper cost or sales issues.
3.41%
Net income growth under 50% of META's 10.17%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.70%
EPS growth under 50% of META's 10.47%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.04%
Diluted EPS growth under 50% of META's 11.04%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.14%
Slight or no buybacks while META is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.08%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
23.71%
OCF growth above 1.5x META's 6.39%. David Dodd would confirm a clear edge in underlying cash generation.
62.21%
Positive FCF growth while META is negative. John Neff would see a strong competitive edge in net cash generation.
3036.47%
10Y revenue/share CAGR above 1.5x META's 1223.16%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1054.73%
5Y revenue/share CAGR above 1.5x META's 190.49%. David Dodd would look for consistent product or market expansions fueling outperformance.
207.37%
3Y revenue/share CAGR above 1.5x META's 77.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
1259.02%
5Y OCF/share CAGR above 1.5x META's 653.02%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
195.79%
3Y OCF/share CAGR above 1.5x META's 125.05%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
3088.17%
Net income/share CAGR 1.25-1.5x META's 2770.56%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
5195.36%
5Y net income/share CAGR above 1.5x META's 304.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
196.29%
3Y net income/share CAGR similar to META's 194.47%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
173.57%
3Y equity/share CAGR above 1.5x META's 66.56%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.80%
Firm’s AR is declining while META shows 14.10%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.01%
Inventory growth of 18.01% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
5.58%
Similar asset growth to META's 5.19%. Walter Schloss finds parallel expansions or investment rates.
5.88%
Similar to META's 5.80%. Walter Schloss finds parallel capital usage or profit distribution strategies.
No Data
No Data available this quarter, please select a different quarter.
3.28%
R&D growth drastically higher vs. META's 6.52%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.88%
SG&A declining or stable vs. META's 12.01%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.